| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/27/2010 | CN101633655A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN100584835C Novel medicinal salt for cinepazide and preparation method thereof |
| 01/27/2010 | CN100584832C 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 01/26/2010 | US7652150 [2-(4-Fluoro-]. H-indol-3-ylsulfanyl)benzyl]dimethyl amine; depression, anxiety disorders including general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks |
| 01/26/2010 | US7652148 Electrophilic aromatic substitution with diacyl imidazolium |
| 01/26/2010 | US7652147 Process for preparation of Irbesartan |
| 01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
| 01/26/2010 | US7652061 (R)-1-{2-[3-(5-Methyl-2-pheny-oxazol-4-ylmethoxy)-phenyl]-acetyl}-pyrrolidine-2-carboxylic acid; dyslipidemia, hyperlipidemia, hypercholesteremia, or type-2 diabetes |
| 01/26/2010 | US7652056 Using 4-imidazoline carboxylic acid or ester; antiinflammatory agents; microbiocides; bactericides; antitumor agenst0 |
| 01/26/2010 | US7652051 3-amino-benzo[1,2,4]triazine-7-ol-1-oxide; 4-[3-(4-chloro-phenylamino)-benzo[1,2,4]triazin-7-yloxy]-pyridine-2-carboxylic acid methylamide trifluoroacetate salt; modulation of the MAPK pathway; cancer |
| 01/26/2010 | US7652041 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity |
| 01/26/2010 | US7652023 Cholesteryl ester transfer protein (CETP) inhibitors; atherosclerosis and cardiovascular diseases; N-(1-(5-chloropyridin-2-yl)-1-(3-fluoro-5-(trifluoromethyl)phenyl)-2-phenylethyl)-4-(trifluoromethyl)thiazol-2-amine |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652010 Azabicyclic aryl derivatives and their medical use |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2430579C Isoindolin-1-one glucokinase activators |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2010009405A2 Targeted nitroxide agents |
| 01/21/2010 | WO2010009139A2 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | WO2010008828A2 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 01/21/2010 | WO2010008761A1 Piperidyl acrylamide antogonists of ccr2 |
| 01/21/2010 | WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007800A1 Novel uracil compound having amide structure and salt thereof |
| 01/21/2010 | WO2010007382A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 01/21/2010 | WO2010007120A1 Pyridazine derivatives as smo inhibitors |
| 01/21/2010 | WO2010007114A2 New chemical compounds |
| 01/21/2010 | WO2010006962A1 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 01/21/2010 | WO2010006945A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | WO2010006940A1 Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes |
| 01/21/2010 | WO2010006938A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 01/21/2010 | WO2009131493A3 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof |
| 01/21/2010 | WO2009120660A3 Substituted pyridoxazines |
| 01/21/2010 | WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof |
| 01/21/2010 | US20100016613 Process for the preparation of a boron-substituted porphyrin |
| 01/21/2010 | US20100016589 Novel Anthranilic Acid Derivative as Potential Anticancer Agent and a Process for the Preparation Thereof |
| 01/21/2010 | US20100016582 Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate |
| 01/21/2010 | US20100016581 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 01/21/2010 | US20100016344 Amino heterocyclic linked pyrimidine derivatives |
| 01/21/2010 | US20100016338 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents |
| 01/21/2010 | US20100016335 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/21/2010 | US20100016332 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 01/21/2010 | US20100016331 Novel compounds |
| 01/21/2010 | US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/21/2010 | US20100016319 Arylmethylene urea derivative and use thereof |
| 01/21/2010 | US20100016318 Anthranilamide inhibitors of aurora kinase |
| 01/21/2010 | US20100016316 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 01/21/2010 | US20100016312 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease |
| 01/21/2010 | US20100016293 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use |
| 01/21/2010 | US20100016290 Amorphous polymorph of bazedoxifene acetate |
| 01/21/2010 | US20100016289 Compounds Useful as Antagonists of CCR2 |
| 01/21/2010 | US20100016279 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155 |
| 01/21/2010 | US20100016275 Novel compound 395 |
| 01/21/2010 | US20100015093 Methods and compositions of treating a flaviviridae family viral infection |
| 01/21/2010 | US20100015092 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/21/2010 | US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them |
| 01/21/2010 | CA2731196A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 01/21/2010 | CA2731130A1 Pyridazine derivatives as smo inhibitors |
| 01/21/2010 | CA2731097A1 Organic compounds |
| 01/21/2010 | CA2730397A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730059A1 Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes |
| 01/21/2010 | CA2730056A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 01/21/2010 | CA2729986A1 New chemical compounds |
| 01/21/2010 | CA2729909A1 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | CA2728616A1 Piperidyl acrylamide antogonists of ccr2 |
| 01/21/2010 | CA2728226A1 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 01/20/2010 | EP2144974A2 Organic electroluminescent device |
| 01/20/2010 | EP2144898A2 Heterocyclic hydrazide compound and pesticidal use of the same |
| 01/20/2010 | EP1663211B1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 01/20/2010 | CN101628888A Inhibitors of cytosolic phospholipase A2 |
| 01/20/2010 | CN100582107C Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/19/2010 | US7649003 Substituted triazole derivatives as oxytocin antagonists |
| 01/19/2010 | US7649002 (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| 01/19/2010 | US7648992 Metalloproteinase 9 and/or 12 inhibitors; such as 5-({[4-[(2-cyclopropylpyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H1)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; synthesis; asthma, chronic obstructive pulmonary disease |
| 01/19/2010 | US7648989 Indolylmaleimide derivatives as PKC inhibitors |
| 01/19/2010 | US7648978 Modulates hepatocyte growth factor (HGF); fibrotic liver disease, hepatic ischemia-reperfusion injury, cerebral infarction, ischemic heart disease, renal disease or lung (pulmonary) fibrosis, multiple sclerosis; 4-[4-(1-homopiperidinyl)phenyl]-1-(2H)-phthalazinone |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648738 for photopolymerization; photography, relief imaging; color filters |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010005879A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | WO2010005876A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/14/2010 | WO2010005783A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | WO2010005782A1 Sulfone compounds which modulate the cb2 receptor |
| 01/14/2010 | WO2010005692A2 Insecticidal cyclic carbonyl amidines |
| 01/14/2010 | WO2010005572A2 Alpha-keto heterocycles as faah inhibitors |
| 01/14/2010 | WO2010005148A2 Novel isoindolinone derivatives having inhibitory activity against t-type calcium channel and method for preparation thereof |
| 01/14/2010 | WO2010004972A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/14/2010 | WO2010004390A1 Quinazoline dione derivatives as trpa1 modulators |
| 01/14/2010 | WO2010004339A1 Processes for the preparation of crystalline forms of sunitinib malate |
| 01/14/2010 | WO2009142771A3 Salts of (r)-5-(2-phenylsulphonylethenyl)-3-(n- methylpyrrolidin-2-ylmethyl)-1h-indole, 5-bromo-3-[(r)-1- methyl-pyrrolidin-2- ylmethyl]-1h-indole and of eletriptan |